A 39 year old man with chronic hepatitis

Seminars in Liver Disease

Volumn 14, Issue 1, 1994, Pages 97-105

  Lawrence, Steven P ^b   Sherman, Kenneth E ^b   Lawson, J Mark ^b   Goodman, Zachary D ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CASE REPORT; CHRONIC HEPATITIS; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENTERITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL;

EID: 0028294358     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007301     Document Type: Article

References (38)

1. Johnson PJ, McFarlane IG: Meeting report: International autoimmune hepatitis group. Hepatology 1993;18:998-1005.
2. Lindor KD, Wiesner RH, LaRusso NF, Dickson ER: Chronic active hepatitis: Overlap with primary biliary cirrhosis and primary sclerosing cholangitis. In: Czaja AJ, Dickson ER, eds. Chronic Active Hepatitis: The Mayo Clinic Experience. New York, Marcel Dekker, 1986;171-187.
3. Schalm SW, Ammon HV, Summerskill WHJ: Failure of customary treatment in chronic active liver disease: Causes and management. Ann Clin Res 1976;8:221-227.
4. Fried MW, Draguesku JO, Shindo M, et al: Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis. Dig Dis Sci 1993;38:631-636.
5. Scully LJ, Clarke D, Barr RJ: Diclofenac induced hepatitis: Three cases with features of autoimmune chronic active hepatitis. Dig Dis Sci 1993;38:744-751.
6. Rodman JS, Deutsch DJ, Gutman SI: Methyldopa hepatitis: A report of six cases and review of the literature. Am J Med 1976;60:941-948.
7. Black M, Mitchell JR, Zimmerman HJ, et al: Isoniazid-associated hepatitis in 114 patients. Gastroenterology 1975;69:289-302.
8. Kloppel G, Seifen G, Lindner H, et al: Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis. Virchows Arch Pathol Anat und Path 1977;373:143-160.
9. Berg PA, Sayers T, Wiedmann KH, et al: Serological classification of chronic cholestatic liver disease by the use of two different types of antimitochondrial antibodies. Lancet 1980;2:1329-1332.
10. Brunner G, Klinge O: A chronic destructive nonsuppurative cholangitis-like disease picture with antinuclear antibodies (immunocholangitis). Deutsche Med Woch 1987;12:1454-1458.
11. Carrougher JC, Shaffer RT, Canales LI, et al: A 33-year-old woman with an autoimmune syndrome. Semin Liver Dis 1991; 11:256-262.
12. Michieletti P, Bassendine MF, Heathcote EJ, et al: Antimitochondrial antibody (AMA) primary biliary cirrhosis (PBC) or autoimmune cholangitis? Hepatology 1992;16:568.
13. Lacerda MA, Lindor KD, Jorgensen RA, et al: "Autoimmune cholangitis" better defines antimitochondrial antibody negative primary biliary cirrhosis. Gatroenterology 1993;104:A933.
14. Ben-ari Z, Dhillon AP, Sherlock S: Autoimmune cholangiopathy: Part of the spectrum of autoimmune chronic active hepatitis. Hepatology 1993;18:10-15.
15. Minuk GY, Sutherland LR, Pappas SC, et al: Autoimmune chronic active hepatitis (lupoid hepatitis) and primary sclerosing cholangitis in two young adult females. Can J Gastroenterol 1988;2:22-27.
16. Rabinovitz M, Demetris AJ, Bou-Abboud CF, Van Thiel DH: Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis. Dig Dis Sci 1992;37:1606-1611.
17. Chapman RWG, Arborgh BAM, Rhoes JM, et al: Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980;21:870-877.
18. Wiesner RH, LaRusso NF, Ludwig J, Dickson ER: Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology 1985;88:108-114.
19. McCarty RL, LaRusso NF, Wiesner RH, Ludwig J: Primary sclerosing cholangitis: findings on cholangiography and pancreatography. Radiology 1983;149:39-14.
20. Li-Yeng C, Goldberg HI: Sclerosing cholangitis: Broad spectrum of radiographic features. Gastrointest Radiol 1984;9:39-47.
21. Ludwig J: Small-duct primary sclerosing cholangitis. Semin Liver Dis 1991;11:11-17.
22. Wiesner RH, La Russo NF: Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980;79:200-206.
23. Wee A, Ludwig J: Pericholangitis in chronic ulcerative colitis: Primary sclerosing cholangitis of the small bile ducts? Ann Int Med 1985;102:581-587.
24. Kaplan MM: Medical approaches to primary sclerosing cholangitis. Semin Liver Dis 1991;11:56-63.
25. Ludwig J, LaRusso NF, Wiesner RH: Primary sclerosing cholangitis. In: Peters RL, Craig JR, eds. Liver Pathology. New York, Churchill Livingstone, 1986;193-214.
26. Portmann B, MacSween RNM: Diseases of the intrahepatic bile ducts. In: MacSween RNM, Anthony PP, Scheuer PJ, eds. Pathology of the Liver, 2nd ed. Edinburgh, Churchill Livingstone, 1987;424-453.
27. Zauli D, Schrumpf E, Crespi C, et al: An autoantibody profile in primary sclerosing cholangitis. J Hepatology 1987;5:14-18.
28. Chapman RW: Role of immune factors in the pathogenesis of primary sclerosing cholangitis. Semin Liver Dis 1991;11:1-4.
29. Bodenheimer HC, LaRusso NF, Thayer WR, et al: Elevated circulating immune complexes in primary sclerosing cholangitis. Hepatology 1983;3:150-154.
30. Whiteside TL, Lasky S, Si L, Van Thiel DH: Immunologic analysis of mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis. Hepatology 1985;5:468-474.
31. Lindor KD, Wiesner RH, Katzmann JA, et al: Lymphocyte subsets in primary sclerosing cholangitis. Dig Dis Sci 1987;32:720-725.
32. Lindor KD, Wiesner RH, LaRusso NF, Homburger HA: Enhanced autoreactivity of T-lymphocytes in primary sclerosing cholangitis. Hepatology 1987;7:884-888.
33. Meyer zum Buschenfelde KH: Autoimmunity and liver disease. Semin Liver Dis 1991;11(3):iii-v.
34. Dienes HP, Autschbach F, Gerber MA: Ultrastructural lesion in autoimmune hepatitis and steps of the immune response in liver tissue. Semin Liver Dis 1991;11:197-204.
35. Mieli-Vergani G, Lobo-Yeo A, McFarlane BM, et al: Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood. Hepatology 1989;9:198-203.
36. Ginsberg GG, Goodman ZD, Lewis JH: A 22-year-old man with thyroid cancer and cholestatic liver disease. Semin Liver Dis 1991;11:64-71.
37. Johnson PJ, McFarlane IG, Eddleston ALWF: The natural course and heterogeneity of autoimmune-type chronic active hepatitis. Semin Liver Dis 1991;11:187-196.
38. Prochazka EJ, Terasaki PI, Park MS, et al: Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med 1990;322:1842-1844.